We are live on ! Find out more
PMVP icon

PMV Pharmaceuticals
PMVP

104 hedge funds and large institutions have $333M invested in PMV Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more call options, than puts

Call options by funds: $3.98M | Put options by funds: $1.6M

24% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 33

3% more capital invested

Capital invested by funds: $324M → $333M (+$9.02M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1.14% less ownership

Funds ownership: 113.06% → 111.92% (-1.1%)

2% less funds holding

Funds holding: 106 → 104 (-2)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

Holders
104
Holders Change
-2
Holders Change %
-1.89%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
41
Reduced
33
Closed
10
Calls
$3.98M
Puts
$1.6M
Net Calls
+$2.38M
Net Calls Change
+$2.28M

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$7.33M
2
Alkeon Capital Management
Alkeon Capital Management
New York
+$5.96M
3
TLP
Tri Locum Partners
New York
+$4.56M
4
OCA
Octagon Capital Advisors
New York
+$2.98M
5
GTC
Ghost Tree Capital
New York
+$2.92M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$4.5M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$4.44M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.41M
4
SFM
Sphera Funds Management
Israel
-$1.18M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$1.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
26
Barclays
United Kingdom
$2.89M +$1.59M +230,692 +96%
NI
27
Nextech Invest
Switzerland
$2.59M -$344K -50,000 -11%
Citigroup
28
Citigroup
New York
$2.24M +$2.07M +301,244 +468%
PCS
29
Personal CFO Solutions
New Jersey
$2.15M – – –
Northern Trust
30
Northern Trust
Illinois
$2.09M +$130K +18,931 +6%
BBA
31
Baker Bros. Advisors
New York
$1.98M – – –
SAM
32
Sectoral Asset Management
Quebec, Canada
$1.87M -$195K -28,426 -9%
Vontobel Holding
33
Vontobel Holding
Switzerland
$1.87M -$195K -28,426 -9%
ACH
34
ArrowMark Colorado Holdings
Colorado
$1.66M – – –
Charles Schwab
35
Charles Schwab
California
$1.66M +$67.1K +9,755 +4%
Assenagon Asset Management
36
Assenagon Asset Management
Luxembourg
$1.59M -$1.12M -162,286 -39%
Morgan Stanley
37
Morgan Stanley
New York
$1.44M -$829K -120,627 -34%
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.04M +$39.4K +5,737 +3%
N
39
Nuveen
North Carolina
$935K -$276K -40,073 -21%
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$922K -$78.2K -11,374 -7%
Bank of America
41
Bank of America
North Carolina
$914K -$323K -46,988 -24%
UBS Group
42
UBS Group
Switzerland
$882K +$316K +45,962 +47%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$764K -$1.71K -248 -0.2%
BCM
44
Bridgeway Capital Management
Texas
$583K – – –
Ameriprise
45
Ameriprise
Minnesota
$505K +$5.95K +865 +1%
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$495K -$189K -27,500 -25%
NYLIM
47
New York Life Investment Management
New York
$458K -$81.7K -11,876 -14%
SSA
48
Schonfeld Strategic Advisors
New York
$438K +$490K +71,295 New
TI
49
Trexquant Investment
Connecticut
$419K +$469K +68,202 New
Qube Research & Technologies (QRT)
50
Qube Research & Technologies (QRT)
United Kingdom
$393K -$323K -46,936 -42%
1
2
3 4 5

PMVP Hedge Fund Activity: Q3 2023 in Review

104 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in PMV Pharmaceuticals (PMVP) for Q3 2023, worth a combined $333M — up 2.8% from $324M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of PMVP and 8 opened new positions — a net loss of 2 holders — while 33 trimmed existing stakes and 41 added.

The largest buyer was PFM Health Sciences, adding an estimated $7.33M. The largest seller was RTW Investments, cutting an estimated $4.5M.

  • 104 institutional investors held PMV Pharmaceuticals (PMVP) as of Q3 2023, down from 106 in Q2 2023.
  • Funds reported $333M of PMV Pharmaceuticals stock for Q3 2023, up 2.8% quarter-over-quarter.
  • 8 funds opened new PMV Pharmaceuticals positions in Q3 2023 and 10 closed out, a net change of -2 holders.
  • The largest PMV Pharmaceuticals buyer in Q3 2023 was PFM Health Sciences, an estimated $7.33M added.
  • The largest PMV Pharmaceuticals seller in Q3 2023 was RTW Investments, an estimated $4.5M sold.

Based on aggregated 13F filings for Q3 2023.